Exercise in Pediatric Autologous Stem Cell Transplant Patients

NCT01666015 | Terminated DMC

• 2 other identifiers: RF-CACICPES01University of Calgary
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 2

Brief Summary

Hematopoietic stem cell transplantation is an intensive therapy used to improve survivorship and cure various oncologic diseases. However, this therapy is associated with high mortality rates and numerous negative side-effects. The recovery of the immune system is a special concern and plays a key role in the success of this treatment. In healthy populations it is known that exercise plays an important role in immune system regulation, but little is known about the role of exercise in the hematological and immunological recovery of children undergoing hematopoietic stem cell transplant. The Primary objective of this Randomized Controlled Trial is: study the effect of an exercise program on immune cell recovery in patients undergoing autologous stem cell transplantation. The Secondary objective is to determine if an exercise intervention might diminish the deterioration of quality of life, physical fitness, and the acquisition of a sedentary lifestyle. Methods Twenty-four participants treated for a malignancy with autologous stem cell transplant (5 to 18 years) in the Alberta Children's Hospital will be randomly assigned to an exercise or control group. The exercise group will participate in a two-phase exercise intervention (in and outpatient) from hospitalization until 10 weeks after discharge. The exercise program includes strength, flexibility and aerobic exercise. During the inpatient phase this program will be performed 5 times/week and will be supervised. The outpatient phase will combine a supervised session with two home-based exercise sessions with the use of the Wii device. The control group will follow the standard protocol without any specific exercise program. A range of outcomes, including quantitative and functional recovery of immune system, cytokine levels in serum, NK cells and their subset recovery and function, and gene expression of activating and inhibitory NK cell receptors, body composition, nutrition, quality of life, fatigue, health-related fitness assessment and physical activity levels will be examined, providing the most comprehensive assessment to date. Discussion We expect to find an improvement in the immunological recovery, quality of life, decreased acquisition of sedentary behavior and less fitness deconditioning.

Conditions

Cancer; Autologous Hematopoietic Stem Cell Transplantation

Keywords

pediatric; exercise; hematopoietic stem cell transplantation; cancer; quality of life; immune system; physical activity levels

Outcome Measures

Primary Outcomes (1)

• Hematological and Immunological Recovery

  Assessment of the impact of the Exercise (EX) intervention on the immune recovery of pediatric autologous SCT patients will be based on four parameters (a) Recovery of different leukocyte cell subset (e.g., T cells, Natural killer cells, B cells, monocytes, neutrophils etc) in peripheral blood by flow cytometry, (b) Expression of activating and inhibitory Killer IRs by Gene expression analysis of 14 KIR genes will be done by RNA based real-time PCR analysis(c) Function of NK cells and their subsets by measuring in-vitro cytokine secretion and degranulation by different NK cell subsets (cytolytic and regulatory NK cells) on incubation with K-562 cell lines and (d) Levels of different pro-inflammatory and regulatory cytokines in serum using a bead-based array on Luminex.

  This assessments will be performed at baseline, 7, 14, 28, 56, 84 and 180 days after stem cell transplantation (SCT)

Secondary Outcomes (1)

• Quality of life (QOL)

  Assessment will be completed at baseline, 30, 90 and 180 days after SCT

Other Outcomes (4)

• Health-related fitness assessment

  Assessment will be completed at baseline, 30 and 90 days after SCT

• Physical activity levels

  Assessment will be completed at baseline, 30, 90 and 180 days after SCT

• Demographic and health assessment

  This assessment will be perfomed at baseline, 15, 30, 60, 90 days after SCT

Study Arms (2)

Exercise (EX)

EXPERIMENTAL

This group will perform two phases of an EX program.

Other: EXERCISE (EX)

Standard Care

ACTIVE COMPARATOR

This group will follow the standard care without any EX prescription.

Other: Standard Care

Interventions

EXERCISE (EX) OTHER

This study will examine the effect of two phases of an EX program on several health related outcomes in pediatric patient undergoing autologous SCT. The first phase of the EX program will be an inpatient intervention and will begin when the child is hospitalized undergoing conditioning therapy and will continue until discharge. The second phase will be a 10-week outpatient intervention, beginning once the child is discharged. We will utilize a mixed EX program, including supervised (at the University of Calgary) and home-based training incorporating the use of the Nintendo ® Wii device™ (Wii Fit, Wii Dance and Sports™ games).

Also known as: PHYSICAL ACTIVITY

Exercise (EX)

Standard Care OTHER

This group will be under standard care without any EX intervention.

Also known as: Active comparator/ control

Standard Care

Eligibility Criteria

• Age: 5 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• autologous SCT at Alberta Children's Hospital (ACH) for malignancy
• age 5 to 18 years of age
• will be receiving myeloablative conditioning regimen
• no evidence of cardiac or pulmonary failure associated with treatment (SF≥28%, EF ≥ 50%)
• no functional nor cognitive limitation that would prohibit performance of the home-based training
• approval by treating oncologist for participants
• a parent or legal guardian must sign the consent form and
• children should express verbal assent to participate.

Sponsors & Collaborators

• University of Calgary: lead
• Alberta Children's Hospital: collaborator

Study Sites (2)

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

Location

Alberta Children's Hospital

Calgary, Alberta, T3B 6A8, Canada

Location

Related Publications (1)

• Chamorro-Vina C, Guilcher GM, Khan FM, Mazil K, Schulte F, Wurz A, Williamson T, Reimer RA, Culos-Reed SN. EXERCISE in pediatric autologous stem cell transplant patients: a randomized controlled trial protocol. BMC Cancer. 2012 Sep 10;12:401. doi: 10.1186/1471-2407-12-401.

  PMID: 22963378 DERIVED

MeSH Terms

Conditions

Neoplasms; Motor Activity

Interventions

Exercise; Standard of Care

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena; Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Study Officials

• Nicole S Culos-Reed, Ph.D

  University of Calgary Faculty of Kinesiology, Faculty of Medicine and Department of Psychosocial Resources, Tom Baker Cancer Centre

  PRINCIPAL INVESTIGATOR

• Carolina Chamorro-Viña, Ph.D

  Faculty of Kinesiology, University of Calgary.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Ph.D, Associate Professor

Study Record Dates

• First Submitted: August 10, 2012
• First Posted: August 16, 2012
• Study Start: June 1, 2012
• Primary Completion: August 1, 2014
• Study Completion: October 1, 2014
• Last Updated: October 26, 2016

Record last verified: 2016-10

Locations

CA (2)